COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,833 Articles (22,553 medRxiv, 8,280 bioRxiv)

Most recent first Previous |  Page 2893: Articles 28921-28930  | Next

Identification and enrichment of SECReTE cis-acting RNA elements in the Coronaviridae and other (+) single-strand RNA viruses
Haimovich, G., Olender, T., Baez, C., Gerst, J. E.
10.1101/2020.04.20.050088 — Posted: 2020-04-20
Early prediction of mortality risk among severe COVID-19 patients using machine learning
Chen, X., Liu, Z.
10.1101/2020.04.13.20064329 — Posted: 2020-04-19
Serial interval and generation interval for respectively the imported and local infectors estimated using reported contact-tracing data of COVID-19 in China
Li, M., Liu, K., Song, Y., Wang, M., Wu, J.
10.1101/2020.04.15.20065946 — Posted: 2020-04-19
Breastfeeding of Infants Born to Mothers with COVID-19: A Rapid Review
Yang, N., Che, S., Zhang, J., Wang, X., Tang, Y., Wang, J., Huang, L., Wang, C., Zhang, H., Baskota, M., Ma, Y., Zhou, Q., Luo, X., Yang, S., Feng, X., Li, W., Fukuoka, T., Ahn, H. S., Lee, M. S., Luo, Z., Liu, E., Chen, Y.
10.1101/2020.04.13.20064378 — Posted: 2020-04-19
Health Education for Parents During the COVID-19 OutbreakPublic Health Education for Parents During the Outbreak of COVID-19: A Rapid Review
Li, W., Liao, J., Li, Q., Baskota, M., Wang, X., Tang, Y., Zhou, Q., Wang, X., Luo, X., Ma, Y., Fukuoka, T., Ahn, H. S., Lee, M. S., Chen, Y., Luo, Z., Liu, E.
10.1101/2020.04.14.20064741 — Posted: 2020-04-19
Prevent the resurgence of infectious disease with asymptomatic carriers
Zhang, Z.
10.1101/2020.04.16.20067652 — Posted: 2020-04-19 Discussion: Onsite | Offsite
The focus and timing of COVID-19 pandemic control measures under healthcare resource constraints
Wei, C., Wang, Z., Liang, Z., Liu, Q.
10.1101/2020.04.16.20067611 — Posted: 2020-04-19
Patient-derived mutations impact pathogenicity of SARS-CoV-2
Yao, H., Lu, X., Chen, Q., Xu, K., Chen, Y., Cheng, L., Liu, F., Wu, Z., Wu, H., Jin, C., Zheng, M., Wu, N., Jiang, C., Li, L.
10.1101/2020.04.14.20060160 — Posted: 2020-04-19 Discussion: Onsite
Rapid development of an inactivated vaccine for SARS-CoV-2
Gao, Q., Bao, L., Mao, H., Wang, L., Xu, K., Yang, m., Li, Y., Zhu, L., Wang, N., Lv, Z., Gao, H., Ge, X., Kan, B., Hu, Y., Liu, J., Cai, F., Jiang, D., Yin, Y., Qin, C., Li, J., Gong, X., Lou, X., Shi, W., Wu, D., Zhang, H., Zhu, L., Deng, W., Li, Y., Lu, J., Li, C., Wang, X., Yin, W., Zhang, Y., Qin, C.
10.1101/2020.04.17.046375 — Posted: 2020-04-19 Discussion: Onsite | Offsite
Exploring Conformational Transition of 2019 Novel Coronavirus Spike Glycoprotein Between Its Closed and Open States Using Molecular Dynamics Simulations
Gur, M., Taka, E., Yilmaz, S. Z., Kilinc, C., Aktas, U., Golcuk, M.
10.1101/2020.04.17.047324 — Posted: 2020-04-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).